日本 卫材,Eisai,  
日本卫材株式会社是一家以研究开发医药产品为主的跨国公司，总部设在日本东京，始建于1941年，其海外分支机构、子公司和工厂分布于欧洲、美洲和亚洲各地。作为一家立足于科研的医药公司，我们十分重视产品研发工作。以筑波研究所为协调中心，大约有1300名研究者在全球昼夜不停的工作，开发下一代有创造性的新药，满足亟待解决的医学需求。我们致力于神经病学、胃肠病学以及肿瘤学专业领域的研究。为了涉足未来的专业领域，我们还在不断把研究拓展到新兴的前沿学科。

卫材（中国）药业有限公司是由卫材株式会社全额投资成立的独资制药企业。卫材株式会社是一家以研究开发医药产品为主的跨国公司，总部设在日本东京。卫材自90年代初进入中国市场以来顺利发展至今。在沈阳成立了沈阳卫材制药有限公司，随后在苏州工业园区成立了制药工厂卫材（苏州）制药有限公司，也就是现在卫材（中国）药业有限公司的前身。并于2002年起更名为卫材（中国）药业有限公司。目前公司在中国销售的药品多达十余种，主要集中在中枢神经系统，消化领域，内分泌和骨科领域。

Eisai Co., Ltd. Japan is a multinational pharmaceutical company with strong R&D capabilities. It was founded in 1941, with the headquarters located in Tokyo. Since its foundation, the Company has actively expanded into overseas markets and now has sales subsidiaries and factories in America, Europe and Asia. As a research-based pharmaceutical company ,we give high priority to research and development activities. With Tsukuba Research Laboratories serving as a coordinating center, approximately 1300 researchers globally work around the clock to develop next-generation and innovative new drugs to satisfy unmet medical needs. Our research is focused on areas of expertise in neurology and gastrointestinal diseases, as well as oncology. We are also expanding research into new frontier areas in order to establish future specialty fields.

Eisai China Inc. is a pharmaceutical company solely invested by Eisai Co., Ltd. Japan, a multinational pharmaceutical company. Eisai has been developing smoothly in China since the early 1990s. It went through Shenyang Eisai and Eisai Suzhou successively (a Japan-funded company, located in Suzhou industrial Park), and later it was renamed as Eisai China Inc. since 2002.